Literature DB >> 8141845

Copper- and malondialdehyde-induced modification of high density lipoprotein and parallel loss of lecithin cholesterol acyltransferase activation.

J C Mazière1, I Myara, S Salmon, M Auclair, J Haigle, R Santus, C Mazière.   

Abstract

Incubation of high density lipoproteins (HDL) with 0.1-10 microM copper ions resulted in a decrease in tryptophan residues and a moderate diminution of lysine residues. Polymerization of apolipoprotein AI (apo A-I) was only observed for the highest concentration of Cu2+. A dose-dependent loss in lecithin cholesterol acyl-transferase (LCAT) activity was noted. Following incubation with 10 mM malondialdehyde, the physicochemical properties of HDL were more pronouncedly affected, in terms of lipid peroxidation products, relative electrophoretic mobility and percentages of intact tryptophan and lysine residues. Polymerization of apo A-I occurred after 40 min incubation, and a time-dependent loss of LCAT activation was noted. Since the deficiency in LCAT activation was observed in relatively mild conditions, when no perturbation of the physico-chemical properties of the particle could be shown, the determination of LCAT activity appears to be a sensitive test for HDL discrete modification.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8141845     DOI: 10.1016/0021-9150(93)90192-w

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

1.  Increased susceptibility to peroxidation of VLDL from non-insulin-dependent diabetic patients: a possible correlation with fatty acid composition.

Authors:  R A Rabini; M Tesei; T Galeazzi; N Dousset; G Ferretti; L Mazzanti
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

2.  Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1.

Authors:  J Greilberger; G Jürgens
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

3.  Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene.

Authors:  D R Booth; S Y Tan; S E Booth; G A Tennent; W L Hutchinson; J J Hsuan; N F Totty; O Truong; A K Soutar; P N Hawkins; M Bruguera; J Caballería; M Solé; J M Campistol; M B Pepys
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

4.  Role of the interfacial binding domain in the oxidative susceptibility of lecithin:cholesterol acyltransferase.

Authors:  Kewei Wang; Papasani V Subbaiah
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

5.  Metal-ion stimulation and inhibition of lysophospholipase D which generates bioactive lysophosphatidic acid in rat plasma.

Authors:  A Tokumura; M Miyake; O Yoshimoto; M Shimizu; K Fukuzawa
Journal:  Lipids       Date:  1998-10       Impact factor: 1.880

6.  Oxidation-induced loss of the ability of HDL to counteract the inhibitory effect of oxidized LDL on vasorelaxation.

Authors:  Laurence Perségol; Marie-Claude Brindisi; David Rageot; Jean-Paul Pais de Barros; Serge Monier; Bruno Vergès; Laurence Duvillard
Journal:  Heart Vessels       Date:  2014-07-17       Impact factor: 2.037

Review 7.  Oxidative risk for atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

8.  Effect of peroxyl radicals on lecithin/cholesterol acyltransferase activity in human plasma.

Authors:  C Chen; G Loo
Journal:  Lipids       Date:  1995-07       Impact factor: 1.880

9.  Apolipoprotein AI-derived pulmonary vascular amyloid in aged dogs.

Authors:  K E Roertgen; E M Lund; T D O'Brien; P Westermark; D W Hayden; K H Johnson
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

10.  Acrolein impairs the cholesterol transport functions of high density lipoproteins.

Authors:  Alexandra C Chadwick; Rebecca L Holme; Yiliang Chen; Michael J Thomas; Mary G Sorci-Thomas; Roy L Silverstein; Kirkwood A Pritchard; Daisy Sahoo
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.